Stocktoria
DENTSPLY SIRONA Inc. XRAY
DENTSPLY SIRONA Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.7B | $3.8B | $4.0B | $3.9B | $4.2B | $3.3B | $4.0B | $4.0B | $4.0B | $3.7B |
| Gross profit | $1.8B | $2.0B | $2.1B | $2.1B | $2.3B | $1.7B | $2.2B | $2.1B | $2.2B | $2.0B |
| R&D expense | $150.0M | $165.0M | $184.0M | $174.0M | $171.0M | $123.0M | $143.0M | $161.0M | $151.7M | $128.5M |
| SG&A expense | $1.4B | $1.6B | $1.6B | $1.6B | $1.6B | $1.3B | $1.6B | $1.7B | $1.7B | $1.5B |
| Operating income | -$422.0M | -$879.0M | -$85.0M | -$937.0M | $608.0M | -$3.0M | $361.0M | -$958.0M | -$1.6B | $454.7M |
| Interest expense | — | — | $81.0M | $65.0M | $61.0M | $48.0M | $30.0M | $37.0M | $38.3M | $35.9M |
| Income tax | $112.0M | -$26.0M | -$43.0M | -$105.0M | $134.0M | $23.0M | $82.0M | $53.0M | -$53.2M | $9.5M |
| Net income | -$598.0M | -$910.0M | -$132.0M | -$950.0M | $411.0M | -$73.0M | $263.0M | -$1.0B | -$1.6B | $429.9M |
| EPS (diluted) | $-3.00 | $-4.48 | $-0.62 | $-4.41 | $1.87 | $-0.33 | $1.17 | $-4.51 | $-6.76 | $1.94 |
| Operating cash flow | $235.0M | $461.0M | $377.0M | $517.0M | $657.0M | $649.0M | $633.0M | $500.0M | $601.9M | $563.4M |
| Free cash flow | — | — | — | $368.0M | $515.0M | $562.0M | $510.0M | $317.0M | $457.6M | — |
| Cash & equivalents | $326.0M | $272.0M | $334.0M | $365.0M | $339.0M | $438.0M | $405.0M | $309.6M | $320.6M | $383.9M |
| Inventory | $642.0M | $564.0M | $624.0M | $627.0M | $515.0M | $466.0M | $562.0M | $598.9M | $623.1M | $517.1M |
| Total assets | $5.4B | $5.8B | $7.4B | $7.6B | $9.2B | $9.3B | $8.6B | $8.7B | $10.4B | $11.6B |
| Total liabilities | $4.1B | $3.8B | $4.1B | $3.8B | $4.2B | $4.4B | $3.5B | $3.6B | $3.7B | $3.4B |
| Shareholders' equity | $1.3B | $1.9B | $3.3B | $3.8B | $5.0B | $5.0B | $5.1B | $5.1B | $6.6B | $8.1B |
Growth · year-over-year · Revenue CAGR -0.2%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | -3.0% | -4.3% | +1.1% | -7.3% | +26.7% | -17.1% | +1.1% | -0.2% | +6.6% | +40.0% |
| Net income growth | — | — | — | -331.1% | — | -127.8% | — | — | -460.5% | +71.1% |
| EPS growth | — | — | — | -335.8% | — | -128.2% | — | — | -448.5% | +65.3% |
| Free cash flow growth | — | — | — | -28.5% | -8.4% | +10.2% | +60.9% | -30.7% | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.